Eli Lilly’s weight loss drugs have delivered blockbuster sales in recent quarters. The company is a leader in this market ...

The European Medicines Agency’s, EMA, committee recommended a change to extend the use of Eli Lilly’s (LLY) Mounjaro for the treatment of type 2 ...

The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for ...

PICKING up her phone, Oonagh Van der Berg goes to read a WhatsApp message – but the 45-year-old, from Belfast, can’t focus.

Goldman Sachs raised the firm’s price target on Eli Lilly (LLY) to $1,145 from $951 and keeps a Buy rating on the shares. Published first on ...

Ozempic has officially arrived in India at a comparatively affordable price, sparking buzz among diabetes and weight loss ...